Clinical Trial Update: Analysis of T and B Cell Repertoire Changes in Response to Orencia® (Abatacept) in Rheumatoid Arthritis

View source ↗

Summary

A clinical trial update analyzing how T and B cell repertoires change in rheumatoid arthritis patients treated with abatacept (Orencia).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ORENCIA (ABATACEPT)

Snippet

Sponsor: Hospital for Special Surgery, New York | Conditions: Rheumatoid Arthritis | Status: RECRUITING